Try our beta test site
7 studies found for:    inhaled treprostinil sodium | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
Conditions: Pulmonary Hypertension;   Chronic Obstructive Pulmonary Disease
Intervention: Drug: Inhaled Treprostinil
2 Recruiting Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
Condition: Respiratory Distress Syndrome, Adult
Interventions: Drug: Treprostinil Inhalation Solution;   Drug: Placebo
3 Recruiting Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Combined Pulmonary Fibrosis and Emphysema
Interventions: Drug: Inhaled Treprostinil;   Drug: Placebo
4 Recruiting Pulmonary Rehab in COPD: Response to Tyvaso
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Intervention: Drug: Inhaled Treprostinil
5 Not yet recruiting Acute Effects of Inhaled Treprostinil in Fontan Patients
Condition: Congenital Heart Disease
Interventions: Drug: Treprostinil;   Drug: Placebo
6 Recruiting Beraprost-314d Added-on to Tyvaso® (BEAT)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Beraprost Sodium 314d Modified Release Tablets;   Drug: Placebo
7 Recruiting Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Condition: Persistent Pulmonary Hypertension of the Newborn
Interventions: Drug: IV Remodulin;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.